SCHEMBL2531322

SCHEMBL2531322

CCc1cc(Cl)nc2cc(F)c(OC)cc12

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.40
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.36
PDPK1 O15530 1/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 2/20 0.35
ELANE P08246 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
PDE3B Q13370 3/20 0.35
PDE3A Q14432 3/20 0.35
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
GSK3B P49841 1/20 0.35
ENPP1 P22413 1/20 0.35
HTR1A P08908 1/20 0.35
TNF P01375 1/20 0.34
MTNR1A P48039 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2534877 0.80 KDM4E (0.44) KDM4EPDPK1ALDH1A1POLBMAPT
SCHEMBL15647874 0.75 EGFR (0.38) KDM4EALDH1A1POLBMAPTHTT
SCHEMBL23882078 0.73 KDM4E (0.54) KDM4EGAAALDH1A1MAPTPDE3B
SCHEMBL5862658 0.72 HTT (0.37) PDE10AKDM4EPDPK1ALDH1A1HTT
SCHEMBL6224039 0.72 DHODH (0.37) PDE10AALDH1A1HTTTNFMTNR1A
SCHEMBL29091604 0.72 SMN1; SMN2 (0.44) KDM4EPDPK1ALDH1A1HTTENPP1
SCHEMBL23520712 0.71 PDE4A (0.42) PDE10APDPK1ALDH1A1PDE3BPDE3A
SCHEMBL19610604 0.71 MAPT (0.50) PDPK1ALDH1A1POLBMAPTPDE3B
SCHEMBL3427577 0.71 KDM4E (0.45) PDE10AKDM4EGAAALDH1A1POLB
SCHEMBL8366935 0.70 PDE3B (0.49) PDE10AKDM4EGAAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044068-B2 Aminopyrrolidine compound TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-10-25 US disclosed
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-11-26 US disclosed
EP-2003131-A1 AMINOPYRROLIDINE COMPOUND Taisho Pharmaceutical Co. Ltd. (JP) 2008-12-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND MC4R, MC5R, MC2R PDE10A 2591/4885KDM4E 728/4885GAA 4242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.